UNIVERSITY OWNED PATENTS
Patents can be viewed by clicking on a Patent number, a PDF of the the patent will open in a new window. To view an Non-confidential Summary of the Technology, click on a file number.
File # |
Country |
Patent No. |
Patent Title |
U-4339 |
United States |
Oligonucleotide Complexes for Use as Anti-Viral Therapeutics |
|
United States |
Regulation Of NAD (P) H Oxidase Growth And Transcription Melanoma Cells |
||
United States |
Method Of Treating Cancer Using Tetraethyl Thiuram Disulfide |
||
Australia |
782029 |
Method of Treating Cancer Using Tetraethyl Thiuram Disulfide |
|
Europe |
Method of Treating Cancer Using Tetraethyl Thiuram Disulfide |
||
United States |
Method Of Treating Cancer Using Dithiocarbamate Derivatives |
||
United States |
Method Of Treating Cancer Using Dithiocarbamate Derivatives |
||
Canadian |
2,251,656 |
Pharmaceutical Compositions Containing Alkylaryl Polyether Alcohol Polymer |
|
Europe |
Pharmaceutical Compositions Containing Alkylaryl Polyether Alcohol Polymer |
||
United States |
Pharmaceutical Compositions Containing Alkylaryl Polyether Alcohol Polymer |
||
Canada |
2,216,789 |
Method Of Mucociliary Clearance In Cystic Fibrosis Patients Using Alkylaryl Polyether Alcohol Polymers |
|
Austria |
Compositions Containing Alkylaryl |
||
Great Britain |
Compositions Containing Alkylaryl |
||
Australia |
717537 |
Method Of Mucociliary Clearance In Cystic Fibrosis Patients Using Alkylaryl Polyether Alcohol Polymers |
|
France |
Compositions Containing Alkylaryl |
||
United States |
Pharmaceutical Compositions Containing Alkylaryl Polyether Alcohol Polymer |
||
United States |
Treatment Of Chronic Pulmonary Inflammation |
||
New Zealand |
263986 |
Method Of Inhibiting Oxidants Using Alkylaryl Polyether Alcohol Polymers |
|
Canada |
2,159,485 |
Method Of Inhibiting Oxidants Using Alkylaryl Polyether Alcohol Polymers |
|
United States |
Method Of Inhibiting Oxidants Using Alkylaryl Polyether Alcohol Polymers |
||
Ireland |
Compostitions Containing Alkylaryl |
||
Italy |
Compositions Containing Alkylaryl |
||
United States |
Method Of Inhibition Oxidants Using Alkylaryl Polyether Alcohol Polymers |
||
United States |
Method Of Mucociliary Clearance In Cystic Fibrosis Patients Using Alkylaryl Polyether AlcoholPloymers |
||
United States |
Prodrugs and Conjugates of Thiol- and Selenol-Containing Compounds and Methods of Use Thereof |
||
United States |
Method of Solution-based Scanning for Alterations in a DNA Segment Using a Double-stranded DNA Binding Dye and Fluorescence Melting Profiles |
||
United States |
Scanning Probe Characterization of Surfaces |
||
United States |
Method for Prediction Prostate Cancer Patients' Resistance to Hormonal Treatment by Measuring Serum Concentrations of Chromogranin A |
||
United States |
Method of Analyzing Dicarboxylic Acids |
||
U-3642 |
United States |
TXu1-117-224 |
Providers United For Improving Inhaler Technique (PUFIIT SCALE) |
United States |
IL-2 Transmembrane Construct |
||
United States |
TXU- 1-050-648 |
Corrosion Virtual Lab |
|
United States |
Disposable Electromagnetic Fluid Level Sensor |
||
United States |
Noninvasive Electromagnetic Fluid Level Sensor |
||
United States |
Continuous Wave Ultrasonic Process Monitor for Polymer Processing |
||
United States |
MED PED FH Make Early Diagnoses - Prevent Early Deaths and Design |
||
United States |
TXU 1-050-649 |
Corrosion Course Modules |
|
United States |
Remediation with Ozone of Sediments Containing Organic Contaminants |
||
United States |
A Current Steering Folding Circuit |
||
United States |
Soluble Steroidal Peptides for Nuclear Acid Delivery |
||
United States |
Method of Use of Erythropoietin to Treat Ischemic Acute Renal Failure |
||
Hong Kong |
1,058,763 |
Compositions and Methods to Improve the Oral Absorption of Antimicrobials |
|
New Zealand |
523276 |
Compositions and Methods for Increasing the Oral Absorption of Antimicrobials |
|
South Africa |
2002/10289 |
Compositions and Methods for Increasing the Oral Absorption of Antimicrobials |
|
United States |
Complexes to Improve Oral Absorption of Poorly Absorbable Antibiotics |
||
U-3203 |
United States |
Oligonucleotide Complexes for Use as Anti-Viral Therapeutics |
|
U-3191 |
United States |
Mu-Conopeptides |
|
U-3189 |
United States |
I-Superfamily Conotoxins |
|
United States |
Medical Broad Band Electromagnetic Holographic Imaging |
||
United States |
High Frequency Thermoacoustic Refrigerator |
||
U-3184 |
United States |
Method of Isolating Human Neuroepithelial Precursor Cells from Human Fetal Tissue |
|
U-3174 |
United States |
Use of Conantokins for Producing Analgesia or for Neuroprotection |
|
U-3174 |
United States |
Use of Conantokins for Producing Analgesia or for Neuroprotection |
|
United States |
Measurement of Crude Oil Wax Precipitation Temperatures and Precipitated Solid Weight Percent Versus Temperature by Infrared Spectroscopy |
||
United States |
Structured Organic Materials and Devices Using Low-Energy Paritcle Beams |
||
United States |
Submerged Ammonia Removal System and Method |
||
United States |
Population of HOXB8 Mutants and Uses in Identifying Agents for Treating Repetitive Behaviors |
||
Europe |
1,401,505 |
Population of HOXB8 Mutants and Uses in Identifying Agents for Treating Repetitive Behaviors |
|
U-3032 |
United States |
Single-Labeled Oligonucleotide Probes for Homogeneous Nucleic Acid Sequence Analysis |
|
U-3021 |
Europe |
Color Compensation for Temperature and Electronic Gains |
|
U-3021 |
Japan |
3657556 |
Color Compensation for Temperature and Electronic Gains |
U-3019 |
United States |
Multi-Test Analysis of Real-Time Nucleic Acid Amplification |
|
U-3018 |
United States |
Method for Quantification of an Analyte |
|
U-3018 |
United States |
Method for Quantification of an Analyte |
|
U-3007 |
United States |
O-Superfamily Conotoxin Peptides |
|
U-2970 |
United States |
Method and Apparatus for Raman Imaging of Macular Pigments |
|
United States |
Mass1 Gene, A Target for Anticonvulsant Drug Development |
||
U-2958 |
United States |
Contryphan Peptides |
|
U-2958 |
United States |
Contryphan Peptides |
|
Australia |
780350 |
Elastin-Based Compositions |
|
United States |
Methods for Extracting Substances Using Alternating Current |
||
U-2907 |
Australia |
768091 |
Tau-Conotoxin Peptides |
U-2907 |
United States |
Tau-Conotoxin Peptides |
|
U-2904 |
Australia |
735724 |
Use of Conotoxin Peptides ImI and MII as Cardiovascular Agents |
U-2903 |
United States |
Use of Conantokins for Treating Pain |
|
U-2903 |
Australia |
735389 |
Use of Conantokins |
U-2903 |
United States |
Use of Conantokins |
|
U-2903 |
United States |
Use of Conantokins |
|
U-2902 |
United States |
Alpha-Conotoxin Peptides |
|
U-2902 |
United States |
Conotoxin Peptides |
|
U-2901 |
Australia |
778353 |
Alpha-Conotoxin Peptides |
U-2901 |
United States |
Alpha-Conotoxin Peptides |
|
U-2901 |
United States |
Alpha-Conotoxin Peptides |
|
U-2897 |
United States |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-2897 |
United States |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-2897 |
United States |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-2896 |
United States |
Methods for Purifying and Assaying a Conus Gamma-Glutamyl Carboxylase |
|
U-2895 |
United States |
Uses of Alpha-Conotoxin Peptides |
|
U-2893 |
United States |
Use of Alpha-Conotoxin MII to Treat Disorders Resulting from Nicotine-Stimulated Dopamine Release |
|
U-2893 |
United States |
Use of Alpha-Conotoxin MII to Treat Disorders Resulting from Nicotine-Stimulated Dopamine Release |
|
U-2893 |
United States |
Use of Alpha-Conotoxin MII to Treat Disorders Resulting from Nicotine-Stimulated Dopamine Release |
|
U-2892 |
United States |
Gamma-Conopeptides |
|
U-2891 |
United States |
Bromo-Tryptophan Conopeptides |
|
U-2890 |
United States |
Contryphan Peptides |
|
U-2889 |
United States |
Conotoxin Peptides AuIA, AuIB and AuIC |
|
U-2888 |
Australia |
727196 |
Conantokins |
U-2888 |
United States |
Conantokins |
|
U-2887 |
Europe |
Conotoxin Peptide PVIIA |
|
U-2887 |
Australia |
724408 |
Conotoxin Peptide PVIIA |
U-2887 |
United States |
Conotoxin Peptide PVIIA |
|
U-2886 |
United States |
Conotoxin Peptide PIIIA |
|
U-2885 |
Australia |
700592 |
Conotoxin Peptides |
U-2885 |
United States |
Conotoxin Peptides |
|
U-2885 |
United States |
Conotoxin Peptides |
|
U-2885 |
United States |
Conotoxin Peptides |
|
U-2884 |
United States |
Omega-Conotoxin Peptides |
|
United States |
Simultaneous Screening and Identification of Sequence Alterations from Amplified Target |
||
United States |
Method to Determine Predisposition to Hypertension |
||
United States |
Fluorescent Cobalamins and Uses Thereof |
||
United States |
Fluorescent Cobalamins and Uses Thereof |
||
United States |
Alterations in the Long QT Syndrome Genes KVLQT1 and SCN5A and Methods for Detecting Same |
||
Australia |
779477 |
Alterations in the Long QT Syndrome Genes KVLQT1 and SCN5A and Methods for Detecting Same |
|
United States |
Alterations in the Long QT Syndrome Genes KVLQT1 and SCN5A and Methods for Detecting Same |
||
United States |
Coaxial Continuous Transverse Stub Element Device Antenna Array and Filter |
||
United States |
Selective Flotation of Phosphate Minerals with Hydroxamate Collectors |
||
United States |
Transgenic Mouse with Endogenous Endoglin Gene Disruption |
||
United States |
Low Temperature Chemical Vapor Depostion of Thin Film Magnets |
||
Australia |
778566 |
MinK-Related Genes, Formation of Potassium Channels and Association with Cardiac Arrhythmia |
|
United States |
MinK-Related Genes, Formation of Potassium Channels and Association with Cardiac Arrhythmia |
||
United States |
Method and Apparatus for Enhancing an Image Using Data Optimization and Segmentation |
||
United States |
Homogeneous Multiplex PCR by Color and Tm |
||
Australia |
780376 |
Cystal Structure of Ribosomal Protein L11/GTPase |
|
United States |
Crystal Structure of Ribosomal Protein L11/GTPase |
||
United States |
Nematode Neuromuscular Junction GABA Receptors and Methods Related Thereto |
||
United States |
Nematode Neuromuscular Junction GABA Receptors and Methods Related Thereto |
||
United States |
Molecular Decomposition Process for the Synthesis of Nanosize Ceramic Powders |
||
Australia |
758256 |
A Molecular Decomposition Process for the Synthesis of Nanosize Ceramic Powders |
|
U-2723 |
United States |
Multiplex Genotyping Using Fluorescent Hybridization Probes |
|
U-2723 |
Japan |
3670967 |
Multiplex Genotyping Using Fluorescent Hybridization Probes |
United States |
Method of Digital Image Enhancement and Sharpening |
||
United States |
Raman Spectroscopy Apparatus and Method for Continuous Cehmical Analysis of Fluid Streams |
||
United States |
Des. 426,783 |
Waveguide Lens |
|
United Kingdom |
2081554 |
Waveguide Lens |
|
Denmark |
MR 1999 00991 |
Waveguide Lens |
|
Switzerland |
125,888 |
Waveguide Lens |
|
Great Britain |
2081553 |
Waveguide Lens |
|
France |
546542 to 546562 |
Waveguide Lens |
|
U-2705 |
United States |
Electrosurgical Electrode with a Conductive, Non-Stick Coating |
|
U-2704 |
United States |
Method and Apparatus for Providing a Conductive, Amorphous Non-Stick Coating |
|
U-2703 |
United States |
Mucin Containing Ophthalmic Preparation |
|
U-2703 |
United States |
Mucin Containing Ophthalmic Preparations |
|
United States |
Drug Screening and Diagnosis Based on Paracrine Tubular Renin-Angiotensin System |
||
U-2669 |
Australia |
771635 |
Methods for Treating Conditions Associated with the Accumulation of Excess Extracellular Matrix |
Australia |
774194 |
MUTATIONS IN AND GENOMIC STRUCTURE OF HERG-A LONG QT SYNDROME GENE |
|
United States |
Mutations In and Genomic Structure of HERG - a Long QT Syndrome Gene |
||
United States |
Actin Mutations in Dilated Cardiomyopathy, a Heritable Form of Heart Failure |
||
United States |
Stabilization and Acoustic Activation of Polymeric Micelles for Drug Delivery |
||
U-2612 |
United States |
Methods and Apparatus for Noninvasive Measurement of Carotenoids and Related Chemical Substances in Biological Tissue |
|
United States |
Circular, Hairpin, Circular/Hairpin, lariat, and Hairpin-Lariat Hammerhead Ribozymes |
||
United States |
Human Diacylglycerol Kinase Iota |
||
U-2565 |
United States |
Micromachined Electrical Field-Flow Fractionation System |
|
United States |
Vesicular Amino Acid Transported Composition and Method |
||
United States |
SID-Polyamide Fusions: A Potent Method of Regulating Gene Expression |
||
United States |
Electrical Detector for Micro-Analysis Systems |
||
United States |
Diagnostic Device and Method |
||
Canada |
2,303,794 |
Diagnostic Device and Method |
|
U-2538 |
United States |
Process for Conversion of Lignin to Reformulated, Partially Oxygenated Gasoline |
|
U-2538 |
United States |
Process for Conversion of Lignin to Reformulated Hydrocarbon Gasoline |
|
U-2536 |
United States |
Lineage Restricted Glial Precursors from the Central Nervous System |
|
U-2536 |
Australia |
765517 |
Lineage-Restricted Precursor Cells Isolated from Mouse Neural Tube and Mouse Embryonic Stem Cells |
U-2536 |
United States |
Lineage Restricted Glial Precursors from the Central Nervous System |
|
United States |
Dual Drive Planetary Mill |
||
United States |
Method for Improving Spatial Resolution and Accuracy in Scanning Probe Microscopy |
||
United States |
KCNQ2 and KCNQ3 - Potassium Channel Genes Which Are Mutated in Benign Familial Neonatal Convulsions (BFNC) and Other Epilepsies |
||
United States |
Mice Which Are +/- or -/- for the Elastin Gene as Models for Vascular Disease |
||
United States |
Human Antithrombin IIIs and Methods Related Thereto |
||
United States |
Organ Preservative Solution Containing Trehalose, Anti-Oxidant, Cations and an Energy Source |
||
South Africa |
98/5887 |
Lineage Restricted Neuronal Precursors |
|
United States |
Isolation of Lineage-Restricted Neuronal Precursors |
||
Australia |
755657 |
Lineage-Restricted Neuronal Precursors |
|
United States |
Method for Preparation of Polythylene Glycol Adehyde Deriviatives |
||
United States |
A Homozygous Mutation in KVLQT1 Which Causes Jervell and Lange-Neilsen Syndrome |
||
United States |
Mutations in the KCNE1 Gene Encoding Human minK Which Cause Arrhythmia Susceptibility Thereby Establishing KCNE1 as an LQT Gene |
||
United States |
Mutations in the KCNE1 Gene Encoding Human minK Which Cause Arrhythmia Susceptibility Thereby Establishing KCNE1 as an LQT Gene |
||
United States |
KVLQT1-A Long QT Syndrome Gene |
||
Australia |
758048 |
KVLQT1 - A LONG QT SYNDROME GENE |
|
United States |
Mutations in the KCNE1 Gene Encoding Human minK whichCause Arrhythmia Susceptibility Therby Establishing KCNE1 as an LQT Gene |
||
U-2455 |
United States |
Metal-Chelating Surfacant |
|
U-2433 |
United States |
Raman Spectroscopy Apparatus and Method Using External Cavity Laser for Continuous Chemical Analysis of Sample Streams |
|
U-2425 |
United States |
Methods for Preventing and Treating Fibrotic Diseases Resulting from Accumulation of Excess Extracellular Matrix Induced by TGFBeta Using Renin Inhibitors |
|
United States |
Dual-Luciferase Reporter System |
||
United States |
Magnetostrictive Composites and Process for Manufacture by Dynamic Compaction |
||
U-2402 |
United States |
Chromosome 17p-Linked Prostate Cancer Susceptibility Gene |
|
U-2402 |
United States |
Chromosome 17P-Linked Prostate Cancer Susceptibility Gene and A Paralog and Orthologous Genes |
|
U-2396 |
United States |
High Power Density Solid Oxide Fuel Cell Having a Graded Anode and the Fuel Cell Thereof |
|
U-2383 |
Australia |
751581 |
Generation, Characterization and Isolation of Neuroepithelial Stem Cells and Lineage Restricted Intermediate Precursor |
U-2383 |
Israel |
132584 |
Generation, Characterization, and Isolation of Neuroepithelial Stem Cells and Lineage Restricted intermediate Precursor |
U-2383 |
United States |
Neuroepithelial Stem Cells and Glial-Restricted Intermediate Precursors |
|
U-2383 |
United States |
Common Neural Progenitor for the CNS and PNS |
|
U-2376 |
Australia |
722998 |
Electromagnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
U-2376 |
Australia |
741418 |
Implantable Centrifugal Blood Pump with Hybrid Magnetic Bearings |
U-2376 |
Australia |
735578 |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
U-2376 |
Australia |
766439 |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
U-2376 |
United States |
Electromagnetically Suspended and rotated Centrifugal Pumping Apparatus and Method |
|
U-2376 |
Canada |
2,253,435 |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Mehtod |
U-2376 |
United States |
Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method |
|
U-2376 |
United Kingdom |
0897476 |
Hybrid Magnetically Suspended and Rotated Centrigugal Pumping Apparatus and Method |
Europe |
Prodrugs and Conjugates of Thiol-and Selenol-Containing Compounds and Methods of Use Thereof |
||
United States |
Prodrugs and Conjugates of Thiol-and Selenol-Containing Compounds and Methods of Use Thereof |
||
Australia |
750916 |
Prodrugs and Conjugates of Thiol-and Selenol-Containing Compounds and Methods of Use Thereof |
|
United States |
DEVICE AND METHOD FOR PRECISION MACULAR IRRADIATOR |
||
United States |
Device and Method for Precision Macular Irradiator |
||
Canada |
2,317,896 |
Method for In Vitro Amplification of Circular DNA |
|
United States |
Method for In Vitro Amplification of Circular DNA |
||
United States |
Improved Rapid Prototyping Method |
||
U-2336 |
United States |
Methods for Preparing Devices Having Metallic Hollow Microchannels on Planar Substrate Surfaces |
|
U-2336 |
United States |
Methods for Preparing Devices Having Metallic Hollow Microchannels on Planar Substrate Surfaces |
|
U-2334 |
United States |
Method and System for Measurement of Macular Carotenoid Levels |
|
U-2334 |
Europe |
Method and System for Measurement of Macular Carotenoid Levels |
|
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
United States |
Bioconjugates and Delivery of Bioactive Agents |
||
Australia |
738431 |
Bioconjugates and Delivery of Bioactive Agents |
|
New Zealand |
334870 |
Bioconjugates and Delivery of Bioactive Agents |
|
United States |
Method of Broad Band Electromagnetic Holographic Imaging |
||
U-2313 |
United States |
Image Reconstruction for Compton Camera Including Spherical Harmonics |
|
U-2313 |
United States |
Image Reconstruction from V-projections Acquired by Compton Camera |
|
U-2301 |
Australia |
729644 |
System and Method for Carrying Out and Monitoring Biological Processes |
U-2301 |
Europe |
Monitoring Hybridization During PCR Using SybrGreen |
|
U-2301 |
Sweden |
Monitoring Hybridization During PCR |
|
U-2301 |
United States |
Monitoring Amplification of DNA During PCR |
|
U-2301 |
Greece |
Monitoring Hybridization During PCR |
|
U-2301 |
United States |
PCR Method for Nucleic Acid Quantification |
|
U-2301 |
Europe |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Portugal |
Monitoring Hybridization During PCR |
|
U-2301 |
Australia |
726501 |
Monitoring Hybridization During PCR |
U-2301 |
Republic of Korea (South Korea) |
0479789 |
Monitoring Hybridization During PCR |
U-2301 |
Spain |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Italy |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
New Zealand |
502323 |
Monitoring Hybridization During PCR |
U-2301 |
Republic of Korea (South Korea) |
0479782 |
System and Method for Carrying Out and Monitoring Biological Processes |
U-2301 |
Belgium |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Great Britain |
Monitoring Hybridization During PCR |
|
U-2301 |
Ireland |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Sweden |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Switzerland |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
France |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Great Britain |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Netherlands |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
|
U-2301 |
Netherlands |
Monitoring Hybridization During PCR |
|
U-2301 |
Republic of Korea (South Korea) |
0479767 |
System and Method for Monitoring for DNA Amplification by Fluorescence |
U-2301 |
Australia |
727296 |
System and Method for Monitoring for DNA Amplification by Fluorescence |
U-2301 |
Monaco |
Monitoring Hybridization During PCR |
|
U-2301 |
Belgium |
Monitoring Hybridization During PCR |
|
U-2301 |
Switzerland |
Monitoring Hybridization During PCR |
|
U-2301 |
Denmark |
Monitoring Hybridization During PCR |
|
U-2301 |
Spain |
Monitoring Hybridization During PCR |
|
U-2301 |
Luxembourg |
Monitoring Hybridization During PCR |
|
U-2301 |
Germany |
697 27 932.4-08 |
System and Method for Carrying Out and Monitoring Polymerase Chain Reactions |
U-2301 |
Italy |
Monitoring Hybridization During PCR |
|
U-2301 |
Ireland |
Monitoring Hybridization During PCR |
|
U-2301 |
Finland |
Monitoring Hybridization During PCR |
|
U-2301 |
France |
Monitoring Hybridization During PCR |
|
U-2295 |
United States |
Method and Apparatus for Analysis of Chromatographic Migration Patterns |
|
United States |
System for Determining Analyte Concentration |
||
Australia |
768,800 |
System for Determining Analyte Concentration |
|
United States |
Oscillation Apparatus and Methods for Multi-Analyte Homogeneous Fluoro-Immunoassays |
||
United States |
Lens and Associatable Flow Cell |
||
United States |
Lens and Associatable Flow Cell |
||
United States |
Lens and Associatable Flow Cell |
||
United States |
Variable Analog Delay Line for Analog Signal Processing on a Single Integrated Circuit Chip |
||
United States |
Diacylglycerol Kinase Isoforms Epsilon and Zeta and Methods of Use Thereof |
||
United States |
Diacylglycerol Kinase Isoforms Epsilon and Zeta and Methods of Use Thereof |
||
United States |
Spinal Fixation Device with Laterally Attachable Connectors |
||
New Zealand |
330743 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
Japan |
3449419 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
Australia |
714527 |
KVLQT1-A Long QT Syndrome Gene Which Encodes KVLQT1 Which Coassembles with minK to form Cardiac Iks Potassium Channels |
|
Republic of Korea (South Korea) |
508845 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
Australia |
714041 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
United States |
KVLQT1 A Long QT Syndrome Gene |
||
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
New Zealand |
330744 |
A LONG QT SYNDROME GENE WHICH ENCODES KVQT1 AND ITS ASSOCIATION WITH minK |
|
United States |
KVLQT1 - A Long QT Syndrome Gene |
||
United States |
Compositions for the Diagnosis and Treatment of Chediak-Higashi Syndrome |
||
United States |
Compositions for the Diagnosis and Treatment of Chediak-Higashi Syndrome |
||
Australia |
717109 |
Cationic Polymer and Lipoprotein-Containing System for Gene Therapy |
|
Republic of Korea (South Korea) |
0536979 |
Cationic Polymer and Lipoprotein-Containing System for Gene Delivery |
|
United States |
Cationic Polymer and Lipoprotein-Containing System for Gene Delivery |
||
United States |
Micromachined Probes for Nanometer Scale Measurements and Methods of Making Such Probes |
||
United States |
Stabilization and Oral Delivery of Calcitonin |
||
United States |
Active Microtubule-Based Separations by Kinesins |
||
United States |
Synthesis of Insulin Derivatives |
||
U-2187 |
United States |
Spiral Cervical Retractor Apparatus |
|
U-2178 |
United States |
Chromosome 11-Linked Coronary Heart Disease Susceptibility Gene CHD1 |
|
United States |
Culture Method for Multilayer Growth of Anchorage-Dependent Cells |
||
U-2167 |
United States |
Method for Mapping Mechanical Property of a Material Using a Scanning Force Microscope |
|
United States |
Scanning Tunneling Charge Transfer Microscope |
||
U-2147 |
United States |
Apparatus and Method for Enhanced Dermal Permeation of Pharmaceuticals |
|
United States |
Device for Radiation Therapy of Rectal Cancer |
||
U-2134 |
United States |
Three-Dimensional SPECT Reconstruction of Combined Cone Beam and Fan Beam Data |
|
United States |
Highlighting Quoted Passages in a Hypertext System |
||
United States |
Targeting of PEG Antibody Conjugates to Islet Cells |
||
United States |
Endotracheal Tube Splitter |
||
United States |
Endotracheal Tube Splitter |
||
U-2090 |
Europe |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Europe |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Greece |
3035631 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Sweden |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
New Zealand |
291624 |
Method for Diagnosing a Predisposition for Breast and Ovarian Cancer |
U-2090 |
New Zealand |
291330 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Japan |
3399539 |
A Method for Diagnosing a Predisposition for Breast and Ovarian Cancer |
U-2090 |
Canada |
2,196,797 |
In Vivo Mutations and Polymorphisms in the 17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Canada |
2,196,795 |
Method for Diagnosing a Predisposition for Breast and Ovarian Cancer |
U-2090 |
Canada |
2,196,790 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Australia |
2196795 |
Method for Diagnosing A Predisposition for Breast and Ovarian Cancer |
U-2090 |
United States |
A 14 Kilobase Deletion in the Promoter Region of BRCA1 in a Breast Cancer Family |
|
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Germany |
DE 695 24 182 T 2 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Greece |
3038516 |
|
U-2090 |
Denmark |
DK/EP 0705902 T3 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
United States |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
|
U-2090 |
Greece |
3036322 |
17q-Linked Breast and Ovarian Cancer Susceptibility Gene |
U-2090 |
Australia |
773601 |
Chromosome 13-Linked Breast Cancer Susceptibility Gene |
United States |
Continuous Solvent Extraction with Bottom Gas Injection |
||
United States |
Formation and Applications of AlCuFe Quasicrystalline Thin Films |
||
United States |
Higher Order Construction Algorithm Method for Rapid Prototyping |
||
United States |
Improved Rapid Prototyping Method |
||
United States |
Quantitative Two-Dimensional Dopant Profile Measurement and Inverse Modeling by Scanning Capacitance Microscopy |
||
U-2059 |
United States |
Methods for Detecting Predisposition to Cancer at the MTS Gene |
|
U-2058 |
New Zealand |
284612 |
Germline Mutations in the MTS Gene and Method for Detecting Predisposition to Cancer at the MTS Gene |
U-2058 |
Australia |
685627 |
Germline Mutations in the MTS Gene and Method for Detecting Predisposition to Cancer at the MTS Gene |
U-2058 |
New Zealand |
328515 |
Germline Mutations in the MTS Gene and Method for Detecting Predisposition to Cancer at the MTS Gene |
U-2058 |
United States |
Germline Mutations in the MTS Gene |
|
U-2055 |
United States |
Rotating and Warping Projector/Backprojector for Converging-Beam Geometries |
|
United States |
Apparatus and Methods for Multi-Analyte Homogeneous Fluoro-Immunoassays |
||
Ireland |
|
||
United States |
Apparatus and Methods for Multianalyte Homogeneous Fluoroimmunoassays |
||
United Kingdom |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
||
Europe |
Apparatus and Methods for Multi-Analyte Homogeneous Fluoro-Immunoassays |
||
Switzerland |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
||
Sweden |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
||
Spain |
ES 2169079 T3 |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
|
United States |
Apparatus and Methods for Multi-Analyte Homogeneous Fluoro-Immunoassays |
||
Germany |
DE694 29 262 T 2 |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
|
Australia |
749504 |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
|
Netherlands |
Apparatus for Multianalyte Homogeneous Fluroimmunoasays |
||
France |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
||
United States |
Apparatus and Methods for Multi-Analyte Homogeneous Fluoro-Immunoassays |
||
Belgium |
0700514 EP |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
|
Denmark |
Apparatus for Multiananlyte Homogeneous Fluroimmunoassays |
||
Australia |
704947 |
Apparatus and Methods for Multi-Analyte Homogeneous Fluoro-Immunoassays |
|
Italy |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
||
Japan |
3426602 |
Apparatus and Methods for Multi-Analyte Homogeneous Flouro-Immonoassays |
|
Austria |
AT E 209 782 T1 |
Apparatus for Multianalyte Homogeneous Fluroimmunoassays |
|
United States |
Method of Measuring Chemical Concentration Based on Spatial Separation and Resolution of Luminescence |
||
U-2035 |
United States |
Mock Circulation System |
|
United States |
Composite Waveguide for Solid Phase Binding Assays |
||
United States |
Composite Waveguide for Solid Phase Binding Assays |
||
United States |
Integrated Optic Waveguide Iimmunosensor |
||
United States |
Composite Waveguide for Solid Phase Binding Assays |
||
United States |
Integrated Optic Waveguide Immunosensor |
||
U-1971 |
Canada |
2,213,198 |
Anti-Transforming Growth Factor-Beta Gene Therapy |
U-1971 |
Great Britain |
Anti-Transforming Growth Factor-Beta Gene Therapy |
|
U-1971 |
Australia |
694621 |
Anti-Transforming Growth Factor-Beta Gene Therapy |
United States |
Marking Pen for Coloring Skin |
||
United States |
Surgical Marking Pen |
||
United States |
Marking Pen for Coloring the Skin |
||
United States |
Alleles |
||
U-1911 |
United States |
Use of Fibromodulin to Prevent or Reduce Dermal Scarring |
|
U-1911 |
Spain |
Inhibitors of Cell Regulatory Factors and Methods for Preventing or Reducing Scarring |
|
U-1911 |
Australia |
673506 |
Inhibitors of Cell Regulatory Factors and Methods for Preventing or Reducing Scarring |
U-1911 |
United States |
Methods of Preventing or Reducing Scarring with Decorin or Biglycan |
|
United States |
Vessel Enhancement Filtering in Magnetic Resonance Angiography |
||
United States |
Immunomodulatory Activity of Exogenous Melatonin Following Traumatic Injury |
||
U-1894 |
United States |
Displaced Center-of-Rotation Fan-Beam Tomography for Cardiac Iimaging |
|
United States |
Automated Hybridization/Imaging Device for Fluorescent Multiplex DNA Sequencing |
||
United States |
Prosthetic Joint with Semipermeable Capsule with Reinforcing Ribs |
||
U-1888 |
United States |
Electronic Calibration of Single Photon Emission Computed Tomography Cameras |
|
U-1887 |
United States |
Conotoxins I |
|
U-1887 |
Spain |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Switzerland |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Italy |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Australia |
678,837 |
Conotoxins I |
U-1887 |
Ireland |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Belgium |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Canada |
2,165,566 |
Conotoxins I |
U-1887 |
France |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Europe |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
United States |
Conotoxins I |
|
U-1887 |
Germany |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Hong Kong |
1039570 |
Contulakin-G, Analogs Thereof and Uses Therefor |
U-1887 |
United States |
Conotoxin Peptides |
|
U-1887 |
Europe |
Conotoxins Having Acetylcholine Receptor Binding Properties |
|
U-1887 |
Netherlands |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
United Kingdom |
Contulakin-G, Analogs Thereof and Uses Therefor |
|
U-1887 |
Canada |
2,420,184 |
Conotoxins |
Australia |
679215 |
Vaccine Compositions and Method for Induction of Immune Response Via Systemic Vaccination |
|
United States |
Vaccine Compositions and Method for Induction of Mucosal Immune Response Via Systemic Vaccination |
||
U-1879 |
Canada |
2,172,989 |
Conotoxin Peptides |
U-1879 |
United States |
Process and Primers for Identifying Nucleic Acids Encoding A-Lineage Conotoxin Peptides |
|
U-1879 |
United States |
Conotoxin Peptides |
|
U-1879 |
United States |
Conotoxin Peptides |
|
U-1879 |
United States |
Conotoxin Peptides |
|
U-1879 |
Europe |
Conotoxin Peptides |
|
U-1879 |
Australia |
681216 |
Conotoxin Peptides |
Canada |
2,262,086 |
Use of A Dehydroepiandrosterone Derivative for Enhancing or Accelerating Re-Epithelialization or Re-Endothelialization of a Tissue |
|
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Method for Enhancing or Accelerating Re-Epithelialization or Re-Endothelialization of a Tissue |
||
United States |
Method for Enhancing or Accelerating Re-Epithelialization or Re-Endothelialization of a Tissue |
||
Germany |
DE 697 12 065 T2 |
Use of Dehydroepiandrosterone Derivative For Enhancing or Accelerating Re-Epithelialization or Re-Endothelialization of a Tissue |
|
Europe |
Use of a Dehydroepiandrosterone Derivative for Enhancing or Accelerating Re-Epithelialization or Re-Endothelialization of a Tissue |
||
Australia |
747137 |
Methods for Preventing Progressive Tissue Necrosis Reperfusion Injury, Bacterrial Translocation and Adult Respiratory Distress Syndrome |
|
United States |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
||
Australia |
736614 |
Method for Reducing Mast Cell Mediated Allergic Reactions |
|
United States |
Methods for Preventing Progessive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
Australia |
677308 |
Dehydroepiandrosterone Derivatives for Preventing Progessive Tissue Necrosis, Reperfusion, Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
|
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
Japan |
2,858,046 |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Tarnslocation and Adult Respiratory Distress Syndrome |
|
Australia |
713850 |
Use of Dehydroepiandrosterone Derivative for Enhancing or Accelerating Re-epithelialization or Re-endothelialization of a Tissue. |
|
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
Italy |
Method for Enhancing or Accelerating Re-Epithelialization or Re-Endothel of Tissue |
||
Australia |
691776 |
Methods of Preventing or Reducing Adult Respiratory Distress Syndrome |
|
Australia |
699749 |
Dehydroepiandrosterone Derivatives for Preventing Progressive Tissue Necrosis Reperfusion, Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
|
Australia |
687704 |
Methods of Preventing or Reducing Bacterial Translocation |
|
United States |
Methods for Preventing Progressive Tissue Necrosis Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Method for Reducing Mast Cell Mediated Allergic Reactions |
||
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Methods for Preventing Progressive Tissue Necrosis Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Methods for Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation and Adult Respiratory Distress Syndrome |
||
United States |
Waveguide Immunosensor with Coating Chemistry and Providing Enhanced Sensitivity |
||
United States |
Waveguide immunosensor with coating chemistry providing enhanced sensitivity |
||
United States |
Waveguide Immunosensor with Coating Chemistry and Providing Enhanced Sensitivity |
||
United States |
Waveguide Immunosensor with Coating Chemistry and Providing Enhanced Sensitivity |
||
U-1874 |
United States |
On-Line DNA Analysis System with Rapid Thermal Cycling |
|
United States |
Seat-Lift Wheelchair |
||
U-1857 |
United States |
Resolution Enhancement for Ultrasonic Reflection Mode Imaging |
|
U-1856 |
United States |
Deletion in Chromosome 17p11.2-12 Which Causes the Disorder Hereditary Neuropathy with Liability to Pressure Palsies |
|
United States |
Diagnosis of Williams Syndrome and Williams Syndrome Cognitive Profile by Analysis of the Presence or Absence of a LIM-Kinase Gene |
||
United States |
Diagnosis and Treatment of Supravalvular Aortic Stenosis and Williams Syndrome |
||
United States |
Diagnosis of Williams Syndrome |
||
Europe |
Diagnosis and Treatment of Supravalvular Aortic Stenosis and Williams Syndrome |
||
Australia |
670990 |
Angiotensinogen Gene Variants and Predisposition to Hypertension |
|
Japan |
3159708 |
Angiotensinogen Gene Variants and Predisposition to Hypertension |
|
United States |
Method to Determine Predisposition to Hypertension |
||
Australia |
754923 |
Method to Determine Predisposition to Hypertension |
|
United States |
Method to Determine Predisposition to Hypertension |
||
United States |
Method to Determine Predisposition to Hypertension |
||
United States |
Methods to Determine Predisposition to Hypertension and Association of Variant Angiotensinogen Gene and Hypertension |
||
New Zealand |
259092 |
Angiotensinogen Gene Variants and Predisposition to Hypertension |
|
United States |
Angiotensinogen Gene Variants and Predisposition to Hypertension |
||
United States |
Method to Determine Predisposition to Hypertension |
||
United States |
Directed Antisense Libraries |
||
U-1811 |
United States |
Impact Inserter Mechanism for Implantation of a Biomedical Device |
|
United States |
Compounds Having the Antigenicity of hCG |
||
France |
Compositions and Kits for Fluorescence Polarization Assays of Large Molecules |
||
Germany |
Compositions and Kits for Fluorescence Polarization Assays of Large Molecules |
||
United States |
Compositions and Kits for Fluorescence Polarization Assay of Large Molecules |
||
United Kingdom |
Compositions and Kits for Fluorescence Polarization Assays of Large Molecules |
||
Switzerland |
Compositions and Kits for Fluorescence Polarization Assays of Large Molecules |
||
Europe |
Compositions and Kits for Fluorescence Polarization Assay of Large Molecules |
||
U-1794 |
United States |
Naamidine A Extracted from Sea Sponges and Methods For its Use as an Anti-Tumor Agent |
|
U-1793 |
United States |
Antineoplastic pyrolo[4,3,2-de]quinolin-8(1H)-ones |
|
U-1763 |
United States |
Preparation of Diamond and Diamond-Like Thin Films |
|
U-1750 |
United States |
Method and System for Error Recovery for Cascaded Servers |
|
U-1748 |
United States |
Muscle and Air Powered LVAD |
|
U-1747 |
United States |
Methods and Apparatus for Analysis of Chromatographic Migration Patterns |
|
U-1742 |
United States |
Coating of Hydrophobic Surfaces to Render them Protein Resistant While Permitting Covalent Attachment of Specific Ligands |
|
U-1742 |
United States |
Compostion and Method for Regulating the Adhesion of Cells and Biomolecules to Hydrophobic Surfaces |
|
U-1742 |
United States |
Coating of Hydrophobic Surfaces to Render Them Protein Resistant While Permitting Covalent Attachment of Specific Ligands |
|
U-1742 |
United Kingdom |
Coating of Hydrophobic Surfaces to Render them Protien Resistant while Permitting Covalent Attachments of Specific Ligands |
|
U-1742 |
France |
Coating of Hydrophobic Surfaces to Render them Protien Resistant while Premitting Covalent Attachments of Specific Ligands |
|
U-1742 |
Canada |
2,277,995 |
Composition and Method for Regulating the Adhesion of Cells and Biomolecules to Hydrophobic Surfaces |
U-1742 |
Sweden |
Coating of Hydrophobic Surfaces to Render them Protien Resistant while Premitting Covalent Attachments of Specific Ligands |
|
U-1726 |
United States |
Muscle Powered Therapeutic Vehicular System |
|
U-1726 |
United States |
Muscle Powered Therapeutic Vehicle |
|
U-1721 |
United States |
Thermionic Optical Emission Device |
|
U-1721 |
United States |
Microminiature Thermionic Vacuum Tube |
|
United States |
Method and Apparatus for Determining Body Composition Using Bioelectrical Impedance |
||
United States |
APC Antibodies |
||
United States |
APC (Adenomatous Polyosis Coli) Protein |
||
United States |
APC Antibodies |
||
United States |
Detection of Inherited and Somatic Mutations of APC Gene in Colorectal Cancer of Humans |
||
United States |
APC Gene and Nucleic Acid Probes Derived Therefrom |
||
Germany |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer of Humans |
||
Austria |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Belgium |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Denmark |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
France |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
United Kingdom |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Greece |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Italy |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Luxembourg |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Netherlands |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Spain |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Switzerland |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Sweden |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
Monaco |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer |
||
United States |
Detection of APC Proteins |
||
Japan |
3330937 |
Inherited and Somatic Mutations of APC Gene in Colorectal Cancer of Humans |
|
United States |
Diagnosis for Mutant APC by Immunoassay |
||
United States |
APC Gene and Nucleic Acid Probes Derived Therefrom |
||
U-1699 |
United States |
Linear Displacement and Strain Measuring Apparatus |
|
U-1699 |
Europe |
Linear Displacement and Strain Measuring Apparatus |
|
U-1699 |
Canada |
2,070,738 |
Linear Displacement and Strain Measuring Apparatus |
U-1693 |
United States |
Rotary Ddisplacement Measuring Apparatus |
|
United States |
Method and Apparatus for Producing Thermodilution Cardiac Output Measurements Utilizing A Neural Network |
||
Austria |
0713534 |
Immunoassay Procedure Utilizing Fluorogenic Tracer Antigens |
|
United States |
Assay Procedure Using Fluorogenic Tracers |
||
United States |
Immunoassay Procedure Utilizing Fluorogenic Tracer Antigens |
||
Denmark |
Immunoassay Procedure Utilizing Fluorogenic Tracer Antigens |
||
France |
Immunoassay Procedure Utilizing Fluorogenic Tracer Antigens |
||
Germany |
Immunoassay Procedure Utilizing Fluorogenic Tracer Antigens |
||
United Kingdom |
Immunoassay Pocedure Utilizing Fluorogenic Tracer Antigens |
||
Sweden |
Immunoassay Procedure Utilizing Fluorogenic Tracer Antigens |
||
Europe |
Immunoassay Procedure Utilizing Flurogenic Tracer Antigens |
||
Netherlands |
Immunoassay Procedure Utilizing Fluorogenic Tracer Antigens |
||
U-1678 |
Europe |
Imaging Methods and Apparatus |
|
U-1678 |
United States |
Cone Beam Reconstruction Using Helical Data Collection Paths |
|
U-1678 |
United States |
Cone Beam Reconstruction Using Combined Circle and Line Orbits |
|
United States |
Long QT Syndrome Genes |
||
U-1670 |
United States |
Simultaneous Transmission and Emission Converging Tomography |
|
U-1670 |
United States |
Simultaneous Ttransmission and Emission Converging Tomography |
|
Austria |
E194660 |
Gene Mutated in Colorectal Cancer |
|
Australia |
664834 |
Gene Mutated in Colorectal Cancer of Humans |
|
Belgium |
Gene Mutated In Colorectal Cancer |
||
United States |
Gene Therapy with MCC |
||
Germany |
Gene that is Mutated in Colorectal Cancer in Humans |
||
Greece |
Gene Mutated in Colorectal Cancer |
||
United Kingdom |
Gene that is Mutated in Colorectal Cancer in Humans |
||
France |
Gene that is Mutated in Colorectal Cancers in Humans |
||
United States |
Diagnosis with MCC |
||
Italy |
Gene Mutated on Colorectal Cancer |
||
Netherlands |
Gene Mutated in Colorectal Cancer |
||
Sweden |
Gene Mutated in Colorectal Cancer |
||
United States |
MCC Protein and Antibody |
||
United States |
MCC Gene (Mutated in Colorectal Cancer) Used for Diagnosis of Cancer in Humans |
||
Switzerland |
Gene Mutated in Colorectal Cancer |
||
Spain |
Gene Mutated in Colorectal Cancer |
||
Denmark |
Gene that is Mutated in Colorectal Cancers in Humans |
||
United States |
Gene Mutated in Colorectal Cancer of Humans |
||
U-1654 |
United States |
Electrical Field-Flow Fractionation Using Redox Couple Added to Carrier Fluid |
|
U-1647 |
United States |
Method of Obtaining Small Conformationally Rigid Conopeptides |
|
United States |
Apparatus and Method for Photogrammetric Surgical Localization |
||
United States |
Apparatus and Method for Photogrammetric Surgical Localization |
||
United States |
Apparatus and Method for Photogrammetric Surgical Localization |
||
U-1626 |
United States |
Pulsatile Drug Delivery Device Using Stimuli Sensitive Hydrogel |
|
U-1622 |
United States |
Robotic Grasping Apparatus |
|
United States |
Rotary Variable Differential Transformer with Eccentric Rotor Core |
||
U-1606 |
United States |
Multiple Vesicle Implantable Drug Delivery System |
|
U-1606 |
United States |
Implantable Drug Delivery System with Piston Actuation |
|
United States |
Power Adjustable Orthopedic Pillow |
||
United States |
Methods for Oral Decorporation of Metals |
||
United States |
Method for Oral Decorporation of Metals |
||
U-1595 |
United States |
Immobilization of Acid-Treated Antibodies on Siliceous Support |
|
United States |
Somatic Mutations in Neurofibromatosis Type 1 Gene in Human Tumors |
||
United States |
Method and Compositions for Identification of Species in a Sample Using Type II Topoisomerase Sequences |
||
U-1535 |
United States |
Eccentric Motion Motor |
|
U-1533 |
United States |
Mechanical/Electrical Displacement Transducer |
|
U-1533 |
United States |
Mechanical/Electrical Displacement Transducer |
|
U-1533 |
United States |
Sliding Contact Mechanical/Electrical Displacement Transducer |
|
U-1533 |
United States |
Sliding Contact Mechanical/Electrical Displacement Transducer |
|
U-1533 |
United States |
Mechanical/Electrical Displacement Transducer |
|
U-1533 |
United States |
Mechanical/Electrical Displacement Transducer |
|
U-1532 |
United States |
Field-Based Movement Sensor |
|
U-1532 |
United States |
Field-Based Movement Sensing Apparatus |
|
U-1532 |
United States |
Field-Based Movement Sensor |
|
United States |
Biodegradable Composites for Internal Medical Use |
||
U-1491 |
Netherlands |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
United States |
Treatment of Glomerulonephritis with Decorin |
|
U-1491 |
Luxembourg |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
Greece |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
Great Britain |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
France |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
Germany |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
United States |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
Switzerland |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
Sweden |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
Australia |
670770 |
Inhibiting Transforming Growth Factor-Beta to Prevent Accumulation of Extracellular Matrix |
U-1491 |
Denmark |
Use of Decorin or Biglycan for the Manufacture of a Medicament in the Treatment of Diabetes-Associated Pathology |
|
U-1491 |
United States |
Inhibition of Transforming Growth Factor Beta Activity |
|
U-1491 |
Belgium |
Suppression of Cell Proliferation by Decorin |
|
U-1491 |
Japan |
2130725 |
Inhibiting Transforming Growth Factor-Beta to Prevent Accumulation of Extracellular Matrix |
U-1491 |
Australia |
633011 |
Suppression of Cell Proliferation by Decorin |
U-1491 |
Canada |
2,065,860 |
Inhibiting Transforming Growth Factor-Beta to Prevent Accumulation of Extracellular Matrix |
U-1491 |
Japan |
2887325 |
Suppression of Cell Proliferation by Decorin |
U-1491 |
Canada |
1340112 |
Suppression of Cell Proliferation by Decorin |
U-1488 |
United States |
Pinched Channel Inlet System for Reduced Relaxation Effects and Stopless Flow Injection in Field-Flow Fractionation |
|
United States |
Method for Determining Blood Pressure Utilizing a Neural Network |
||
U-1457 |
United States |
Apparatus and Method for Noninvasive Blood Glucose Monitoring |
|
U-1457 |
United States |
Apparatus and Methods for Noninvasive Blood Substance Monitoring |
|
U-1450 |
United States |
Cells and Non-Human Organisms Containing Predetermined Geonomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same |
|
United States |
Positive-Negative Selection Methods and Vectors |
||
United States |
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same |
||
United States |
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same |
||
United States |
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same |
||
United States |
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same |
||
United States |
Method for Augmenting Immunological Responses |
||
United States |
Methods for Augmenting Immunological Responses Through the Administration of Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-Sulfate (DHEA-S) |
||
Australia |
667018 |
Use of Steroid Hormones in Compositions for Inducing T Cell Lymphokine Production |
|
United States |
Method for Enhancement of Production of Lymphokines and Applications Thereof |
||
United States |
Vaccine Compositions and Method for Enhancing an Immune Response |
||
United States |
Vaccine Compositions and Method for Enhancing an Immune Response |
||
U-1435 |
United States |
Synthesis of Peptides as Cloned Ubiquitin Extensions |
|
U-1435 |
United States |
Synthesis of Peptides as Cloned Ubiquitin Extensions |
|
U-1433 |
United States |
Rapid Thermal Cycling Device |
|
U-1433 |
United States |
Method for Rapid Thermal Cycling of Biological Samples |
|
U-1417 |
United States |
Method for Coal Liquefaction |
|
U-1417 |
United States |
Method for Coal Liquefaction |
|
United States |
Tactile Testing Device |
||
United States |
Apparatus for Automated Tactile Testing |
||
U-1403 |
Europe |
Drug Delivery System for the Simultaneous Delivery of Drugs Activatable by Enzymes and Light |
|
U-1403 |
Denmark |
Drug Delivery System for the Simultaneous Delivery of Drugs Activatable by Enzymes and Light |
|
United States |
Fossil Resin Flotation from Coal by Selective Coagulation and Depression of Coal |
||
U-1393 |
United States |
Apparatus and Method for Sampling |
|
U-1390 |
United States |
Servovalve Apparatus for Use in Fluid Systems |
|
U-1390 |
United States |
Servovalve Apparatus for Use in Fluid Systems |
|
U-1370 |
United States |
Method and Apparatus for Decoding Multiple Bit Sequences that are Transmitted Simultaneously in a Single Channel |
|
U-1364 |
Russia |
2048505 |
Apparatus and Process for the Production of Acetylene |
U-1364 |
Australia |
645043 |
The Two Stage Process for Production of Calcium Chloride and Acetylene |
U-1364 |
Canada |
2,067,815 |
Apparatus and Process for the Production of Acetylene |
United States |
Dynamic Multivane Electron ARC Beam Collimator |
||
U-1354 |
United States |
Air Sparged Hydrocyclone Flotation Apparatus and Methods for Separating Particles from a Particulate Suspension |
|
U-1351 |
United States |
Patellazole |
|
U-1328 |
United States |
Method of Preventing Tooth Decay by Laser Beam Irradiation and Chemical Treatment |
|
United States |
Colonic-Targeted Oral Drug-Dosage Forms Based on Crosslinked Hydrogels Containing Azobonds and Exhibiting PH-Dependent Swelling |
||
U-1319 |
United States |
Three-Dimensional Electrode Device |
|
United States |
Rapid Line Scan NMR Imaging |
||
U-1314 |
United States |
Method and Apparatus for Modification of Supercooled Fog |
|
United States |
Method of Making Jet Fuel Compositions Via a Dehydrocondensation Reaction Process |
||
U-1300 |
United States |
Method and System for Spline Interpolation, and Their Use in CNC |
|
U-1281 |
United States |
Percutaneous Drug Delivery System |
|
United States |
Heterogeneous Interpenetrating Polymer Networks for the Controlled Release of Drugs |
||
Europe |
Human Polymorphic VNTR Markers |
||
Canada |
1,339,493 |
Genetic Identification Employing DNA Probes of Variable Number Tandem Repeat Loci |
|
United States |
Genetic identification Employing DNA probes of Variable Number Tandem Repeat Loci |
||
United States |
Genetic Identification Employing DNA Probes of Variable Number Tandem Repeat Loci |
||
U-1205 |
United States |
Apparatus for Simultaneous Visualization and Measurement of Fluorescence from Fluorescent Dye Treated Cell Preparations and Solutions |
|
United States |
Mycoplasma Arthritidis T-cell Mitogen |
||
United States |
Mycoplasma Arthritidis Superantigen |
||
United States |
Mycoplasma Arthritidis T-Cell Mitogen |
||
U-1153 |
United States |
Spider Toxins and Methods for Their Use as Blockers of Calcium Channels and Amino Acid Receptor Function |
|
U-1153 |
United States |
Spider Toxins and Methods for Their Use as Blockers of Amino Acid Receptor Function |
|
U-1153 |
United States |
Isolation and Use of Spider Toxins |
|
U-1153 |
United States |
Spider Toxins and Methods for Their Use as Blockers of Calcium Channels and Amino Acid Receptor Function |
|
U-1134 |
Denmark |
Methods and Compositions for Noninvasive Administration of Sedatives, Analgesics, and Anesthetics |
|
U-1134 |
Europe |
Composition and Methods of Manufacture of Oral Dissolvable Medicaments |
|
U-1134 |
Europe |
Compositions and Methods of Manufacture of Oral Dissolvable Medicaments |
|
U-1134 |
Denmark |
Apparatus and Methods for Use in Administering Medicaments by Direct Medicament Contact to Mucosal Tissues |
|
U-1134 |
Sweden |
Methods and Compositions for Noninvasive Administration of Sedatives, Analgesics, and Anesthetics |
|
U-1134 |
United States |
Apparatus and Methods for Use in Administering Medicaments by Direct Medicament Contact to Mucosal Tissues |
|
U-1134 |
United States |
Compositions and Methods of Manufacture of Compressed Powder Medicaments |
|
U-1134 |
Australia |
645265 |
Compositions and Methods for Noninvasive Blood Glucose Monitoring |
U-1134 |
United States |
Compositions of Oral Dissolvable Medicaments |
|
U-1134 |
United States |
Compositions of Oral Nondissolvable Matrixes for Transmucosal Administration of Medicaments |
|
U-1134 |
Europe |
Methods and Compositions for Noninvasive Administration of Sedatives, Analgesics, and Anesthetics |
|
U-1134 |
Norway |
19920854 |
Methods and Compositions for Noninvasive Dose-to-Effect Administration of Liphphilic Drugs |
U-1134 |
Norway |
19920857 |
Compositions and Methods of Manufacture of Oral Dissolvable Medicaments |
U-1134 |
Japan |
2758985 |
Methods and Compositions for Noninvasive Dose-to-Effect Administration of Liphphilic Drugs |
U-1134 |
United States |
Methods and Compositions for Noninvasive Dose-to-Effect Administration of Drugs with Cardiovascular or Renal Vascular Activities |
|
U-1134 |
Germany |
P68992222.5 |
Compressed Powder Medicaments |
U-1134 |
Australia |
643233 |
Apparatus for Administering Medicaments to Mucosal Tissue |
U-1134 |
United States |
4,863,737 |
Methods and Compositions for Noninvasive Administration of Sedatives, Analgesics, and Anesthetics |
U-1134 |
Australia |
642664 |
Transmucosal Dosage Form |
U-1134 |
Denmark |
DK 175773 B1 |
Methods and Compositions for Noninvasive Dose-to-Effect Administration of Liphphilic Drugs |
U-1134 |
Canada |
2,066,403 |
Transmucosal Dosage Form |
U-1134 |
United States |
Methods and Compositions for Noninvasive Dose-to-Effect Administration of Drugs with Cardiovascular or Renal Vascular Activities |
|
U-1134 |
United States |
Selectively Removable Nicotine-Containing Dosage Form for Use in the Transmucosal Delivery of Nicotine |
|
U-1134 |
Switzerland |
Compositions and Methods of Manufacture of Oral Dissolvable Medicaments |
|
U-1134 |
United States |
Non-Dissolvable Drug-Containing Dosage-Forms for use in the Transmucosal Delivery of a Drug to a Patient |
|
U-1134 |
Canada |
2,066,425 |
Apparatus and Methods for Use in Administering Medicaments by Direct Medicament Contact to Mucosal Tissues |
U-1134 |
Japan |
2717024 |
Compositions of Oral Dissolvable Medicaments |
U-1134 |
Spain |
2 133 448 |
Compositions and MEthods pf Manufacture of Oral Dissolvable Medicaments |
U-1134 |
Norway |
319057 |
Tobacco Substitute |
U-1134 |
Japan |
2580076 |
Apparatus and Methods for Use in Administering Medicaments By Direct Medicament Contact to Mucosal Tissue |
U-1134 |
Japan |
2784347 |
Tobacco Substitute |
U-1134 |
Australia |
645966 |
Methods and Compositions for Noninvasive Dose-to-Effect Administration of Liphphilic Drugs |
U-1134 |
Europe |
Apparatus and Methods for Use in Administering Medicaments by Direct Medicament Contact to Mucosal Tissues |
|
U-1134 |
United States |
Compositions and Methods of Manufacturing of Oral Dissolvable Medicaments |
|
U-1134 |
United States |
Tobacco Substitute |
|
U-1134 |
Canada |
2,178,021 |
Tobacco Substitute |
U-1110 |
United States |
Flow-Through Methods and Apparatus for Iontophoresis Application of Medicaments at a Comtrolled PH |
|
U-1110 |
United States |
Methods and Apparatus for Iontophoresis Application of Medicaments at a Controlled pH Through Ion Exchange |
|
U-1110 |
Japan |
1932611 |
Methods and Apparatus for Iontophoresis Application of Medicaments at a Controlled pH Through Ion Exchange |
U-1110 |
Germany |
3785789.4 |
Methods and Apparatus for Iontophoresis Application of Medicaments |
U-1078 |
Canada |
1,317,066 |
A Ligand for Forming Radiolabeled Technetium Chelates for Use in Renal Function Determinations |
U-1078 |
Canada |
1,292,084 |
A Ligand for Forming Radiolabeled Technetium Chelates for Use in Renal Function Determinations |
U-1078 |
United States |
Radiolabeled Technetium Chelates for Use in Renal Function Determinations |
|
U-1078 |
United States |
Radiolabeled Technetium Chelates for Use in Renal Function Determinations |
|
U-1078 |
United States |
Radiolabeled Technetium Chelates for Use in Renal Function Determinations |
|
U-0701 |
United States |
Method and apparatus for fabrication of thin film semiconductor devices using non-planar, exposure beam lithography |
|
U-0701 |
United States |
Method and apparatus for fabrication of micro-structures using non-planar, exposure beam lithography |
|
U-0701 |
United States |
Movement Actuator/Sensor System |
|
U-0701 |
United States |
Peritoneal Dialysis System |

